Akouos to Present Nonclinical Data from AK-OTOF and AK-antiVEGF Programs at the American Society of Gene and Cell Therapy 24th Annual Meeting
BOSTON, April 27, 2021 (GLOBE NEWSWIRE) — Akouos, Inc. (NASDAQ: AKUS), a precision genetic medicine…
BOSTON, April 27, 2021 (GLOBE NEWSWIRE) — Akouos, Inc. (NASDAQ: AKUS), a precision genetic medicine…
SAN DIEGO, April 27, 2021 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced…
PHILADELPHIA and OXFORDSHIRE, United Kingdom, April 27, 2021 (GLOBE NEWSWIRE) — Adaptimmune Therapeutics plc (Nasdaq:ADAP),…
– engEx™ Platform and in vitro and in vivo findings support utility across multiple therapeutic…
Presentations include initial results from preclinical studies of expanded pipeline programs in immune-mediated and metabolic…
WALTHAM, Mass., April 27, 2021 (GLOBE NEWSWIRE) — Affinia Therapeutics, an innovative gene therapy company…
MENLO PARK, Calif., April 27, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:…
Orphazyme A/SInvestor news No. 05/2021Company Registration No. 32266355 Copenhagen, Denmark and Chicago, IL, USA, April 27, 2021…
BUFFALO, N.Y., April 27, 2021 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical…
SEATTLE, April 27, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial stage…
IRVINE, Calif., April 27, 2021 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late…
SALT LAKE CITY, April 27, 2021 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a…
Includes Pivotal Phase 3 Alzheimer’s Asset NE3107 Cuong V. Do Named CEO of The New…
The combined company, Palisade Bio, Inc., is expected to commence trading on the Nasdaq Capital…
BETHESDA, Md., April 27, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (NASDAQ: GANX) (“Gain”) a…
NEW YORK, April 27, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq:…
– Granted Priority Medicines designation by the European Medicines Agency for CTX001™ for transfusion-dependent beta…
SOUTH SAN FRANCISCO, Calif., April 27, 2021 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS),…
SAN CARLOS, Calif., April 27, 2021 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL…